Jasmine Breitbach, CFA, MBA, Senior Analyst with Valencia who is covering the Company, stated, "Based on the growth potential of Metatron's (MRNJ) suite of product and services, and the valuation of related comparables, we believe the stock is undervalued and are assigning a fair market value the stock at $1.11 a share."